Deal data, CRC developments, and the unglamorous prep work that separates a full-price sale from a discount — written by a broker who has spent four decades doing New Jersey transactions.
One sentence in 17:30-9.9 requires a contract with an approved New Jersey employee assistance program. The three written policies named directly above it are all optional, and an Appellate Division ruling in May put a price on that choice.
Read the analysis →
Impact zone status is attached to the premises, so it rides along with an assignment of the lease. Social equity and diversely-owned status are attached to the owners, which is why a buyer prices them at zero.
Read the analysis →
New Jersey charges a cannabis microbusiness half of every license fee and caps nothing about how many it will issue. It also forbids the sale or transfer of that license, which makes the conversion application the only exit there is.
Read the analysis →
A New Jersey cannabis invoice is typically paid on day fifty-six, and 38.4 percent of what the state's suppliers are owed is more than ninety-one days late. Read one invoice backwards and you find a loan nobody papered, on either side.
Read the analysis →
A blind teaser is how a New Jersey cannabis business goes to market without its staff, its landlord or its competitors finding out first. Four live listings show how easily a page with no name on it still gives the answer away.
Read the analysis →
Under N.J.A.C. 17:30-7.16 an adult-use licensee renews with an application and a fee, and the Commission's renewal letters never mention the town. Jersey City requires a council resolution anyway - and it is the one approval with no deadline, no published standard and no appeal.
Read the analysis →
Curaleaf just raised its hostile bid for Aurora to an implied US$5.00 a share, and every figure behind it is public. Try to price one New Jersey dispensary and six of the numbers you need are not published anywhere - here is what buyers substitute, and what each swap costs them.
Read the analysis →
New Jersey's minimum wage goes to $16.48 on January 1, and the lowest legal hourly rate in state retail will still be $6.61. Neither one is what you pay a budtender, and neither one is what a buyer prices.
Read the analysis →
An owner-occupier charging himself $4,000 a month thinks he is being thrifty. That one figure sets both the value of his dispensary and the value of the roof over it - and a buyer will reprice both.
Read the analysis →
A first New Jersey dispensary gets built with your own money, somebody else's, or both - and N.J.A.C. 17:30-6.8 already decided what each of those people is allowed to receive. Here are the 2026 market rates, the Commission's fees, and the one license class the state's own loan program will not fund.
Read the analysis →
An eighth that has sat for sixty days is worth about three quarters of its menu price, and nobody signed off on that. Here are the five decisions that put it there, the five cadences that catch it, and the disposal rule waiting at the end.
Read the analysis →
A buyer's markup is not a renegotiation - every subtraction on it was already sitting in the letter of intent. Here are the six lines that move a New Jersey cannabis price between the handshake and the wire, and the stage where each one is actually decided.
Read the analysis →
New Jersey still requires a labor peace agreement as an ongoing material condition of a cannabis license, even after a federal judge held the requirement preempted in August. Three operators have now sued, and a notice of violation reaches your bank, your landlord and your supplier before it reaches a hearing.
Read the analysis →
New Jersey dispensaries moved about 10 percent more product in September 2026 and took in 1.4 percent more money for it. Both numbers are true, and a buyer who underwrites only one of them pays the wrong price.
Read the analysis →
A Bridgeton cultivator grew cannabis outdoors on its own licensed property, and as of this week its Class 1 license stops working. The rules that cost operators the most in New Jersey are not about handling cannabis - they are about changing anything.
Read the analysis →
Owners reach for the liquor license comparison because it is the only scarcity asset most of us watched appreciate. It is the wrong comparable in six specific ways, and each one points at where the value in a New Jersey cannabis business actually sits.
Read the analysis →
On March 31, 2026 the New Jersey Cannabis Regulatory Commission took a recorded vote on whether one redacted employee could work in a cannabis business. Here is what a first ten-person payroll actually costs to get legally onto the floor, seat by seat.
Read the analysis →
Category 5 violations start at $5,000, and each day out of compliance counts separately - all of it set out in a table the Commission wrote for licensees to read. Here is what is already on the state's website, what the monitoring reports reveal about how a case gets built, and the free channel almost no New Jersey operator uses.
Read the analysis →
The New Jersey Cannabis Regulatory Commission approves ownership transfers in the open, in batches, at meetings it schedules itself - and only two of those are left in 2026. Here is the calendar your closing date actually runs on, gate by gate.
Read the analysis →
On November 13, 2026, New Jersey's liquor stores stop selling THC drinks, and any hemp beverage above 0.4 milligrams of total THC per container becomes cannabis - made only by a Class 2, sold only by a Class 5. The trade press is asking whether the date will hold; these are the six questions nobody is asking.
Read the analysis →
Curaleaf is chasing Aurora for $272 million and Vireo is building toward 270 dispensaries, and none of it involves buying a single New Jersey store. Here is the roll call of who actually bids on a New Jersey cannabis business, and the first question each one asks.
Read the analysis →
Ascend Wellness is advertising a Fort Lee general manager from $100,000 and a Plainfield operator is at $72,500. On a store worth under $2 million, not having one can cost eight times that at closing.
Read the analysis →
One CRC resolution approved seventeen ownership transfers and named all seventeen companies, while redacting every individual owner. Here is exactly what becomes public when a New Jersey cannabis business changes hands, and in what order.
Read the analysis →
The CRC received 3,128 applications and approved 2,412 of them, yet only 397 businesses are licensed to operate. Approval is not the bottleneck in New Jersey, and the gaps that hold a file up are the same ones every time.
Read the analysis →
Every cannabis ad in New Jersey carries a sixty-word mandatory warning, and Facebook shows about 125 characters before it truncates. Here are the six terms that decide what you may say about your own store — and the three channels still worth paying for.
Read the analysis →
The price on the first page of a purchase agreement is a headline. The indemnification article near the back decides how much of it you actually receive, and when.
Read the analysis →
Growing one plant in New Jersey is still a third-degree crime, and two bills would change that. Here is how a buyer prices all three outcomes into your store.
Read the analysis →
TerrAscend closed on Aunt Mary's in Flemington for $9 million on September 16. Earlier this year three AYR stores changed hands for no storefront price at all — and both numbers are correct.
Read the analysis →
Online cannabis orders run $68.01 and 3.9 items against $50.56 and 2.7 items at the counter, and roughly a quarter of dispensary sales now start on a screen. Here is a 30-minute audit of your own menu, the New Jersey rules that govern it, and what fixing it is worth when you sell.
Read the analysis →
Buyers open with “we'll do this as an asset purchase,” and in New Jersey cannabis that position cannot survive the rulebook. A six-step decision tree covering the two-year ownership lockout, CRC approval, the 280E step-up that isn't worth what buyers think, and the bulk-sale question to put to your CPA.
Read the analysis →
Every buy-versus-build comparison runs the calendar forward, which flatters the build side. Run it backwards from opening day and the real costs show up: months of rent before revenue, a Commission meeting you do not control, and a 12.6% conversion rate.
Read the analysis →
A North Jersey operator sent me a delivery ticket showing $78 of product, a $10 fee and a forty-one minute round trip, then asked why the delivery line never grows. Here it is marked up line by line — the labor, the CRC rules, the 280E question, and the reason your delivery zone probably stops in the wrong place.
Read the analysis →
The buyer's kickoff call is scheduled for an hour and runs forty minutes, and five requests decide the tone of everything after it. Here is that call, annotated, from the CRC file to the Form C-9600 bulk sale notice.
Read the analysis →
New Jersey employers filed 127 WARN notices in 2026 and exactly one came from a cannabis company. The real count of distressed operators is spread across five ledgers kept by five different institutions, and nobody adds them up.
Read the analysis →
A reported Article 9 foreclosure sale of New Jersey cannabis collateral is set for October 6, and the Commission's next public meeting is October 29. Here is what the gavel actually conveys, what survives it, and why the gap between the sale date and the approval date is where distressed cannabis buyers lose money.
Read the analysis →
Session fees at a New Jersey consumption lounge run around five dollars per thirty minutes, and roughly six lounges are open against more than three hundred dispensaries. The endorsement is not a revenue line, it is a traffic decision, and under current CRC guidance it is also a one-per-company decision.
Read the analysis →
A relocatable New Jersey Class 5 retail license is listed this month at $69,000, and a pre-operational Class 1 cultivation license at $175,000. In July a single Flemington dispensary traded on a $9 million valuation, and almost none of that difference is the license.
Read the analysis →
The CRC has been turning conditional applications around in roughly four to five weeks, and annual and conversion applications in 12 to 26. The town has no such clock, and no New Jersey cannabis application moves without a resolution from its governing body naming you and your proposed location.
Read the analysis →
Retail shrink runs about 1.6 percent of sales nationally and roughly two-thirds of it is theft rather than paperwork. In a New Jersey dispensary that number also carries a regulator: a reportable loss has to reach the Commission within three hours of discovery.
Read the analysis →
New Jersey cannabis space runs roughly $15 to $40 a square foot on a business that cannot casually move, because the CRC ties your license to a specific address and most towns still say no. That makes one paragraph of your lease worth more to your sale price than almost anything on your P&L.
Read the analysis →
New Jersey's social equity excise fee has sat at $2.50 an ounce while the statutory ceiling for its price tier is $30 — and the tier table gets more permissive as cannabis gets cheaper. The CRC reopens the question on October 29.
Read the analysis →
Florida's 2026 adult-use ballot question died about 47,000 signatures short, and Pennsylvania's legalization bill has sat in a Senate committee since May 2025. New Jersey has 272 open dispensaries, 358 towns that want nothing to do with them, and a two-year ownership lockout most out-of-state buyers have never heard of.
Read the analysis →
New Jersey flower has fallen from about $12.49 a gram to $8.09, and the cheapest remaining lever is getting existing customers back more often. But the loyalty program that does it answers to four separate rulebooks, and only one of them comes from the CRC.
Read the analysis →
A buyer's accountant spends about six hours with your file before deciding what your store is worth to them, and they are not reading your P&L. They are testing whether Metrc, your POS, your bank deposits and your filed returns tell the same story.
Read the analysis →
A standard conditional cannabis application in New Jersey costs $200 to submit and $800 on approval. The license is the cheapest part of the whole thing - here is what each of the six classes actually permits, and what each one is worth when it changes hands.
Read the analysis →
New Jersey stores sold 2.5 percent more units in August 2026 than a year earlier and still booked 2.8 percent less revenue. That gap is price compression, and four numbers already sitting in your POS decide whether you fight it or absorb it.
Read the analysis →
The SBA is closed to cannabis, SAFE Banking is still a bill, and institutional cannabis credit is pricing near 16 percent. That leaves the seller as the lender - here is how to carry paper without carrying all of the risk.
Read the analysis →
In July, TerrAscend paid roughly $9 million for a single dispensary in Flemington. Three months later, another New Jersey operator's collateral is headed to an Article 9 foreclosure sale - same state, same license rules, opposite outcomes.
Read the analysis →Whether you are thinking about selling, or looking to buy into the New Jersey market from out of state, the first conversation costs nothing and stays between us.
If you just want to know the number, I will tell you the number.